Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from NICE

NYT Connections today hints and answers — Thursday, September 19 (#466)

Need help with Connections #466? Here are some hints and the answers.

Tom’s Guide

Ten of the best-value deals from this summer’s transfer window

Close to £5bn was spent by Europe’s top five men’s leagues – but which players may prove to be worth the fees paid?

The Guardian - UK

Europa League and Conference League draw: As they happened

The Europa League and Conference League have drawn some fantastic fixtures for the league stage of the competition

FourFourTwo

From analysis to the latest developments in health,
read the most diverse news in one place.

Every footballer to have received a perfect 10 from L’Equipe: featuring Lionel Messi, Ademola Lookman and Neymar

Only 15 players in football history have achieved a perfect 10/10 match rating from the prestigious publication.

FourFourTwo

UK drug regulator approves Alzheimer's drug but government likely won't pay for it

Britain’s drug regulator has authorized the Alzheimer’s drug Leqembi, saying that it’s the first medicine to show some impact in slowing progression of the neurodegenerative disease

The Independent UK

What you need to know about lecanemab – the Alzheimer’s drug rejected for NHS use

The drug has been developed by Eisai, a Japanese pharmaceutical company, and is sold under the brand name Leqembi

The Independent UK

What is Lecanemab and who makes it? Alzheimer’s drug gets approval but will not be available on the NHS

NICE says drug is not cost effective and shares fears of side effects

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

First drug to slow Alzheimer’s progression will not be made available on the NHS

The spending watchdog has recommended that a drug shown to slow the progression of Alzheimer’s disease should not be rolled out on the NHS.

The Independent UK

UK health regulator rejects lecanemab as treatment for Alzheimer’s

Decision by Nice to rule out drug being available on NHS comes despite medicines licensing body giving green light

The Guardian - UK

Women in England to be offered a daily tablet for fibroids, Nice says

About 30,000 patients with moderate to severe symptoms could receive Linzagolix, which may shrink growths

The Guardian - UK

One third of NHS psychosis services used to treat patients like Valdo Calocane are failing standards

Health minister Wes Streeting said Barnaby Webber, Grace O’Malley-Kumar and Ian Coates “might still be alive” today if “the NHS had been there when it should have been”

The Independent UK

Jean-Clair Todibo set for West Ham medical after loan deal agreed for £34m defender considered by Man United

Man United opted against move for Nice defender due to fears of breaching UEFA rules on multi-club ownership

Evening Standard

$NHS to offer new drug to prevent bone fractures in postmenopausal women$

NHS to offer new drug to prevent bone fractures in postmenopausal women

Abaloparatide, which could help more than 14,000 women with osteoporosis, to be available in England within three months

The Guardian - UK

New drug to tackle weak bone symptom of the menopause

Abaloparatide – which is sold as Eladynos and made by Theramex – has been given the green light for NHS use

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Thousands of postmenopausal women to benefit from bone-strengthening drug on NHS

The treatment increases bone density by stimulating the cells that make new bone.

The Guardian - UK

ME: we need more funding and more research

Letters: people with myalgic encephalomyelitis and their carers are calling for a reversal of decades of underfunding

Top News

Manchester United In Talks For Swap Deal With Inter Milan

Stay updated with the latest transfer news as clubs in Europe engage in negotiations and potential deals during the summer transfer window.

The Guardian - UK

UK must move towards disease prevention to save economy and NHS, says expert

Personalised ‘pre-NHS’ could stop onset of disease and offer health checks in places people live, work and socialise

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Højlund, Immobile, Thuram: men’s transfers you may have missed during Euro 2024

With the tournament now over, the important business of signings will again command our attention

Evening Standard

West Ham agree Jean-Clair Todibo loan deal with £26.8m purchase option

Hammers still face competition from Juventus to seal transfer

The Independent UK

What is the QbTest for ADHD, how long does it take for diagnosis and who can take it?

The QbTest could speed up diagnosis for young people being assessed for the three symptoms of ADHD

The Guardian - UK

ADHD digital test approved for NHS use in England and Wales

Experts hope QbTest will help more children get diagnosis within six months of first assessment

The Guardian - UK

Struggle to find TV deal leaves French football clubs fearing bankruptcy

League president Vincent Labrune predicted broadcast revenues of €1bn a season but reality has proved different

The Conversation

Is it still a good idea to take aspirin to prevent heart disease? Here’s what the evidence says

You might have heard that taking a daily low-dose aspirin can reduce your risk of developing heart disease. But, unless you have been told to take aspirin by your doctor, recent news should make you think again, because, for many, the risks outweigh the benefits.

The Independent UK

Uefa hand down multi-club ownership verdict involving Manchester United and Man City

Participation in European competitions had been in doubt until the matters were solved

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UEFA Champions League

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.